Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners, Advancing Innovative Virtual-First Care Service
Summary
DALLAS, April 11, 2023--(BUSINESS WIRE)--Recuro Health (Recuro), an integrated digital health solutions company designed to transition the U.S. healthcare system from a reactive, disease-focused model to a proactive care approach, today announces the closing of a $47 million Series B round investment. "The continued support of our investors is a clear sign of their confidence in our mission," says Michael Gorton, CEO and founder, Recuro Health. "We have an extraordinary team at Recuro dedicated to evolving healthcare to be more proactive and personal, resulting in improved outcomes, better patient engagement and lower costs. This nimble organization has the ability to quickly respond to market changes, scale its tech-enabled services and close gaps in care that improve population health. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories.